Finished
Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM)
NCT04866992 · University of Texas Southwestern Medical Center · Updated 21 Jan 2022
- What is being tested
- Not stated
- For
- Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Ductal Carcinoma in Situ; Prognostic Stage I Breast Cancer AJCC v8; Prognostic Stage II Breast Cancer AJCC v8; BRCA1 Mutation; BRCA2 Mutation
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 10 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 1 Feb 2020, ends 24 Sept 2021. Registered 30 April 2021.
- Results
- None posted yet.
In the researchers' words
This is a prospective registry trial to determine the outcomes of single port robot-assisted nipple sparing mastectomy (SPrNSM) utilitzing the SP da Vinci surgical system.
Sites
- UT Southwestern Medical CenterDallas, Texas, United States